AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
MOLECULAR-IDENTIFICATION OF INFECTIOUS AGENTS IN PRIMARY BILIARY-CIRRHOSIS
Authors: TANAKA A PRINDIVILLE T SOLNICK J COPPEL RL LAKE J KEEFFE E GISH R GERSHWIN ME
Citation: A. Tanaka et al., MOLECULAR-IDENTIFICATION OF INFECTIOUS AGENTS IN PRIMARY BILIARY-CIRRHOSIS, Hepatology, 28(4), 1998, pp. 301-301
INTRAMUSCULAR HEPATITIS-B IMMUNE GLOBULIN COMBINED WITH ORAL LAMIVUDINE FOR PROPHYLAXIS AGAINST HEPATITIS-B RECURRENCE AFTER LIVER-TRANSPLANTATION
Authors: YAO F OSORIO R ROBERTS J POORDAD F STEADY S GISH R
Citation: F. Yao et al., INTRAMUSCULAR HEPATITIS-B IMMUNE GLOBULIN COMBINED WITH ORAL LAMIVUDINE FOR PROPHYLAXIS AGAINST HEPATITIS-B RECURRENCE AFTER LIVER-TRANSPLANTATION, Hepatology, 28(4), 1998, pp. 391-391
HEPATOCELLULAR-CARCINOMA - DATA FROM THE CALIFORNIA CANCER REGISTRY
Authors: YAO F GISH R POORDAD F RODIVEN R
Citation: F. Yao et al., HEPATOCELLULAR-CARCINOMA - DATA FROM THE CALIFORNIA CANCER REGISTRY, Hepatology, 28(4), 1998, pp. 715-715
A RANDOMIZED TRIAL OF INTERFERON-ALPHA-2B, DAILY VS. 3 TIMES A WEEK FOR ONE MONTH, FOLLOWED BY 3 TIMES A WEEK FOR ONE-YEAR IN COMBINATION WITH RIBAVIRIN IN PATIENTS WHO HAVE FAILED A PREVIOUS COURSE OF INTERFERON
Authors: GISH R YAO F BROOKS L POORDAD F SCHULZE G
Citation: R. Gish et al., A RANDOMIZED TRIAL OF INTERFERON-ALPHA-2B, DAILY VS. 3 TIMES A WEEK FOR ONE MONTH, FOLLOWED BY 3 TIMES A WEEK FOR ONE-YEAR IN COMBINATION WITH RIBAVIRIN IN PATIENTS WHO HAVE FAILED A PREVIOUS COURSE OF INTERFERON, Hepatology, 28(4), 1998, pp. 1648-1648
POST ORTHOTOPIC LIVER-TRANSPLANTATION ANTIVIRAL THERAPY AND IMMUNOPROPHYLAXIS AGAINST RECURRENT HEPATITIS-B
Authors: POORDAD F YAO F GISH R STEADY S OSORIO R ROBERTS J FAIMANN Y
Citation: F. Poordad et al., POST ORTHOTOPIC LIVER-TRANSPLANTATION ANTIVIRAL THERAPY AND IMMUNOPROPHYLAXIS AGAINST RECURRENT HEPATITIS-B, Hepatology, 28(4), 1998, pp. 2288-2288
CHARACTERIZATION OF HEPATITIS-G VIRUS (GB-C VIRUS) PARTICLES - EVIDENCE FOR A NUCLEOCAPSID AND EXPRESSION OF SEQUENCES UPSTREAM OF THE E1 PROTEIN
Authors: XIANG JH KLINZMAN D MCLINDEN J SCHMIDT WN LABRECQUE DR GISH R STAPLETON JT
Citation: Jh. Xiang et al., CHARACTERIZATION OF HEPATITIS-G VIRUS (GB-C VIRUS) PARTICLES - EVIDENCE FOR A NUCLEOCAPSID AND EXPRESSION OF SEQUENCES UPSTREAM OF THE E1 PROTEIN, Journal of virology, 72(4), 1998, pp. 2738-2744
DUAL EFFECTS OF HEPATITIS-B (HBV) INFECTION AND HEPATITIS-B IMMUNOGLOBULIN (HBIG) IN REDUCING THE INCIDENCE OF ACUTE REJECTION POSTTRANSPLANTATION
Authors: PESSOA MG KIM E MARTIN P CRIPPIN J KEEFFE E GISH R ASCHER N WRIGHT TL TERRAULT NA
Citation: Mg. Pessoa et al., DUAL EFFECTS OF HEPATITIS-B (HBV) INFECTION AND HEPATITIS-B IMMUNOGLOBULIN (HBIG) IN REDUCING THE INCIDENCE OF ACUTE REJECTION POSTTRANSPLANTATION, Gastroenterology, 114(4), 1998, pp. 507-507
IMPROVED SURVIVAL OF HEPATITIS-B PATIENTS UNDERGOING LIVER-TRANSPLANTATION - EFFECTS INDEPENDENT OF THERAPEUTIC INTERVENTIONS
Authors: TERRAULT NA PESSOA MG SINGLETON S KIM E MARTIN P CRIPPIN J GISH R KEEFFE E LAKE J ASCHER N WRIGHT TL
Citation: Na. Terrault et al., IMPROVED SURVIVAL OF HEPATITIS-B PATIENTS UNDERGOING LIVER-TRANSPLANTATION - EFFECTS INDEPENDENT OF THERAPEUTIC INTERVENTIONS, Hepatology, 26(4), 1997, pp. 195-195
LONG-TERM LAMIVUDINE THERAPY OF PATIENTS WITH RECURRENT HEPATITIS-B POST LIVER-TRANSPLANTATION
Authors: PERRILLO R RAKELA J MARTIN P LEVY G SCHIFF E WRIGHT T DIENSTAG J GISH R VILLENEUVE JP CALDWELL S BROWN N SELF P
Citation: R. Perrillo et al., LONG-TERM LAMIVUDINE THERAPY OF PATIENTS WITH RECURRENT HEPATITIS-B POST LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 196-196
DIFFERENT PATTERNS OF HBV S-GENE-MUTATIONS IN LIVER-TRANSPLANT (OLT) PATIENTS (PTS) WITH AND WITHOUT HBV REINFECTION
Authors: XING J GHANY M VILLAMIL F ROJTER S GISH R VIERLING J LOK ASF
Citation: J. Xing et al., DIFFERENT PATTERNS OF HBV S-GENE-MUTATIONS IN LIVER-TRANSPLANT (OLT) PATIENTS (PTS) WITH AND WITHOUT HBV REINFECTION, Hepatology, 26(4), 1997, pp. 197-197
MUTATIONS IN THE HBV PRE-S REGIONS ARE ASSOCIATED WITH MORE SEVERE LIVER-DISEASE
Authors: XING J HUSSAIN M ROJTER S GISH R VILLAMIL F VIERLING J LOK ASF
Citation: J. Xing et al., MUTATIONS IN THE HBV PRE-S REGIONS ARE ASSOCIATED WITH MORE SEVERE LIVER-DISEASE, Hepatology, 26(4), 1997, pp. 363-363
LAMIVUDINE FOR SUPPRESSION AND OR PREVENTION OF HEPATITIS-B WHEN GIVEN PRE/POST LIVER-TRANSPLANTATION (OLT)/
Authors: PERRILLO R RAKELA J MARTIN P WRIGHT T LEVY G SCHIFF E DIENSTAG J GISH R DICKSON R ADAMS P BROWN N SELF P
Citation: R. Perrillo et al., LAMIVUDINE FOR SUPPRESSION AND OR PREVENTION OF HEPATITIS-B WHEN GIVEN PRE/POST LIVER-TRANSPLANTATION (OLT)/, Hepatology, 26(4), 1997, pp. 526-526
SERIAL ANALYSIS OF THE COMPLETE HEPATITIS-B VIRUS NUCLEOTIDE-SEQUENCES IN PATIENTS WITH FIBROSING CHOLESTATIC HEPATITIS AFTER LIVER-TRANSPLANTATION
Authors: FISCHER L MULLERRUCHHOLTZ C GUNTHER S GISH R WILL H STERNECK M
Citation: L. Fischer et al., SERIAL ANALYSIS OF THE COMPLETE HEPATITIS-B VIRUS NUCLEOTIDE-SEQUENCES IN PATIENTS WITH FIBROSING CHOLESTATIC HEPATITIS AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 1514-1514
MUTATION OF HUMAN KERATIN-18 IN ASSOCIATION WITH CRYPTOGENIC CIRRHOSIS
Authors: KU NO WRIGHT TL TERRAULT NA GISH R OMARY MB
Citation: No. Ku et al., MUTATION OF HUMAN KERATIN-18 IN ASSOCIATION WITH CRYPTOGENIC CIRRHOSIS, The Journal of clinical investigation, 99(1), 1997, pp. 19-23
S-GENE ESCAPE MUTANTS AS A CAUSE OF HBV REINFECTION IN PATIENTS WHO RECEIVED HBIG POST-LIVER TRANSPLANT (LT)
Authors: GHANY MG AYOLA B VILLAMIL FG GISH R ROJTER S VIERLING JM LOK ASF
Citation: Mg. Ghany et al., S-GENE ESCAPE MUTANTS AS A CAUSE OF HBV REINFECTION IN PATIENTS WHO RECEIVED HBIG POST-LIVER TRANSPLANT (LT), Journal of investigative medicine, 44(1), 1996, pp. 32-32
HBIG INDUCED HBV-S GENE-MUTATIONS IN LIVER-TRANSPLANT (LT) RECIPIENTSCAN REVERT AFTER WITHDRAWAL OF HBIG
Authors: AYOLA B GHANY MG VILLAMIL FG GISH R ROJTER S VIERLING JM LOK ASF
Citation: B. Ayola et al., HBIG INDUCED HBV-S GENE-MUTATIONS IN LIVER-TRANSPLANT (LT) RECIPIENTSCAN REVERT AFTER WITHDRAWAL OF HBIG, Hepatology, 24(4), 1996, pp. 221-221
LAMIVUDINE FOR HEPATITIS-B AFTER LIVER-TRANSPLANTATION (OLT)
Authors: PERRILLO R RAKELA J MARTIN P LEVY G SCHIFF E WRIGHT T DIENSTAG J GISH R VILLENEUVE J CALDWELL S BROWN N SELF P
Citation: R. Perrillo et al., LAMIVUDINE FOR HEPATITIS-B AFTER LIVER-TRANSPLANTATION (OLT), Hepatology, 24(4), 1996, pp. 223-223
HBV REINFECTION IN LIVER-TRANSPLANT (LT) PATIENTS (PTS) WHO REMAINED HBSAG NEGATIVE POST-LT
Authors: GHANY MG AYOLA B VILLAMIL FG GISH R ROJTER S VIERLING JM LOK ASF
Citation: Mg. Ghany et al., HBV REINFECTION IN LIVER-TRANSPLANT (LT) PATIENTS (PTS) WHO REMAINED HBSAG NEGATIVE POST-LT, Hepatology, 24(4), 1996, pp. 1165-1165
S-GENE ESCAPE MUTANTS AS A CAUSE OF HBV REINFECTION IN PATIENTS WHO RECEIVED HBIG POST-OLT
Authors: GHANY MG AYOLA B VILLAMIL FG GISH R ROITER S VIERLING JM LOK ASF
Citation: Mg. Ghany et al., S-GENE ESCAPE MUTANTS AS A CAUSE OF HBV REINFECTION IN PATIENTS WHO RECEIVED HBIG POST-OLT, Hepatology, 22(4), 1995, pp. 174-174
SURVIVAL AFTER LIVER-TRANSPLANTATION FOR HBV-LIVER FAILURE IS UNRELATED TO PRECORE STOP CODON MUTATION
Authors: GHANY MG VILLAMIL FG GISH R ROITER S VIERLING JM LOK ASF
Citation: Mg. Ghany et al., SURVIVAL AFTER LIVER-TRANSPLANTATION FOR HBV-LIVER FAILURE IS UNRELATED TO PRECORE STOP CODON MUTATION, Hepatology, 22(4), 1995, pp. 1255-1255
MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS
Authors: MARTINEZ OM VILLANUEVA JC LAWRENCEMIYASAKI L QUINN MB GISH R COX K SO S ESQUIVEL CO KRAMS SM
Citation: Om. Martinez et al., MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(1), 1995, pp. 1211-1212
TREATMENT OF RECURRENT PANCREATITIS BY ENDOSCOPIC DRAINAGE OF A DUODENAL DUPLICATION
Authors: LANG T BERQUIST W RICH E COX K DEVRIES P CAHILL J BAKER E GISH R
Citation: T. Lang et al., TREATMENT OF RECURRENT PANCREATITIS BY ENDOSCOPIC DRAINAGE OF A DUODENAL DUPLICATION, Journal of pediatric gastroenterology and nutrition, 18(4), 1994, pp. 494-496
GLUTATHIONE-S-TRANSFERASE AS MARKER IN THE DIAGNOSIS OF REJECTION IN LIVER-TRANSPLANT RECIPIENTS - A PRELIMINARY-REPORT
Authors: BURNS W GISH R BERQUIST W SEVERSON E ESQUIVEL C
Citation: W. Burns et al., GLUTATHIONE-S-TRANSFERASE AS MARKER IN THE DIAGNOSIS OF REJECTION IN LIVER-TRANSPLANT RECIPIENTS - A PRELIMINARY-REPORT, Hepatology, 20(4), 1994, pp. 10000335-10000335
OPTIMIZATION FOR THE DETECTION OF HEPATITIS-C VIRUS-ANTIGENS IN THE LIVER
Authors: GONZALEZPERALTA RP FANG JWS DAVIS GL GISH R TSUKIYAMAKOHARA K KOHARA M MONDELLI MU LESNIEWSKI R PHILLIPS MI MIZOKAMI M LAU JYN
Citation: Rp. Gonzalezperalta et al., OPTIMIZATION FOR THE DETECTION OF HEPATITIS-C VIRUS-ANTIGENS IN THE LIVER, Journal of hepatology, 20(1), 1994, pp. 143-147
FAILURE TO DETECT CELL-SURFACE EXPRESSION OF HEPATITIS-C VIRUS (HCV) STRUCTURAL PROTEINS USING A VACCINIA EXPRESSION SYSTEM
Authors: FANG JWS LAU GKK MAROUSUS C GONZALEZPERALTA RP DAVIS GL GISH R MOYER RW KAO KJ LESNIEWSKI R MIZOKAMI M HOUGHTON M LAU JYN
Citation: Jws. Fang et al., FAILURE TO DETECT CELL-SURFACE EXPRESSION OF HEPATITIS-C VIRUS (HCV) STRUCTURAL PROTEINS USING A VACCINIA EXPRESSION SYSTEM, Gastroenterology, 106(4), 1994, pp. 10000890-10000890
Risultati: 1-25 | 26-27